EP2037954A4 - Method for modulating the pharmacokinetics and metabolism of a therapeutic agent - Google Patents

Method for modulating the pharmacokinetics and metabolism of a therapeutic agent

Info

Publication number
EP2037954A4
EP2037954A4 EP07812192A EP07812192A EP2037954A4 EP 2037954 A4 EP2037954 A4 EP 2037954A4 EP 07812192 A EP07812192 A EP 07812192A EP 07812192 A EP07812192 A EP 07812192A EP 2037954 A4 EP2037954 A4 EP 2037954A4
Authority
EP
European Patent Office
Prior art keywords
pharmacokinetics
metabolism
modulating
therapeutic agent
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07812192A
Other languages
German (de)
French (fr)
Other versions
EP2037954A2 (en
Inventor
Gary M Eichenbaum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of EP2037954A2 publication Critical patent/EP2037954A2/en
Publication of EP2037954A4 publication Critical patent/EP2037954A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01031—Beta-glucuronidase (3.2.1.31)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP07812192A 2006-06-20 2007-06-19 Method for modulating the pharmacokinetics and metabolism of a therapeutic agent Withdrawn EP2037954A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81522306P 2006-06-20 2006-06-20
PCT/US2007/071510 WO2007149827A2 (en) 2006-06-20 2007-06-19 Method for modulating the pharmacokinetics and metabolism of a therapeutic agent

Publications (2)

Publication Number Publication Date
EP2037954A2 EP2037954A2 (en) 2009-03-25
EP2037954A4 true EP2037954A4 (en) 2011-09-14

Family

ID=38834295

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07812192A Withdrawn EP2037954A4 (en) 2006-06-20 2007-06-19 Method for modulating the pharmacokinetics and metabolism of a therapeutic agent

Country Status (2)

Country Link
EP (1) EP2037954A4 (en)
WO (1) WO2007149827A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102097026B (en) * 2009-12-14 2013-04-10 中国科学院上海药物研究所 Device and method for simulating pharmacokinetics characteristics in vitro

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279824A (en) * 1988-04-14 1994-01-18 Merck Patent Gmbh Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis
US20040071685A1 (en) * 2002-10-09 2004-04-15 Devin Houston Compositions and methods for increasing the bioavailability of plant polyphenols
US20050260186A1 (en) * 2003-03-05 2005-11-24 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
WO2006042056A2 (en) * 2004-10-08 2006-04-20 The Ohio State University Methods and compositions for enzyme-specific activation of carbohydrate-conjugated prodrugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4236237A1 (en) * 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, their preparation and use as medicines
PT648503E (en) * 1993-09-22 2000-11-30 Hoechst Ag PRO-PROFARMACOS, ITS PRODUCTION AND UTILIZATION
KR100270650B1 (en) * 1994-12-23 2000-11-01 돈 리사 로얄 Antibody directed enzyme prodrug therapy using mutated form of host enzymes
WO2003097609A1 (en) * 2002-05-15 2003-11-27 Janssen Pharmaceutica N.V. N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
WO2005021494A2 (en) * 2003-06-13 2005-03-10 Immunomedics, Inc. D-amino acid peptides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279824A (en) * 1988-04-14 1994-01-18 Merck Patent Gmbh Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis
US20040071685A1 (en) * 2002-10-09 2004-04-15 Devin Houston Compositions and methods for increasing the bioavailability of plant polyphenols
US20050260186A1 (en) * 2003-03-05 2005-11-24 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
WO2006042056A2 (en) * 2004-10-08 2006-04-20 The Ohio State University Methods and compositions for enzyme-specific activation of carbohydrate-conjugated prodrugs

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HOUBA P H ET AL: "Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER 15 FEB 2001 LNKD- PUBMED:11251980, vol. 91, no. 4, 15 February 2001 (2001-02-15), pages 550 - 554, XP002655272, ISSN: 0020-7136 *
YAN Z ET AL: "N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-c]pyra zol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases", DRUG METABOLISM AND DISPOSITION, vol. 34, no. 5, May 2006 (2006-05-01), pages 748 - 755, XP002655273, ISSN: 0090-9556 *

Also Published As

Publication number Publication date
WO2007149827A3 (en) 2009-04-23
EP2037954A2 (en) 2009-03-25
WO2007149827A2 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
EP1906923A4 (en) Systems and methods for delivery of a therapeutic agent
GB0625659D0 (en) Therapeutic compounds and their use
EP2001383A4 (en) Devices and methods for creating continuous lesions
IL195819A0 (en) Modulators of metabolism and the treatment of disorders related thereto
IL195851A0 (en) Modulators of metabolism and the treatment of disorders related thereto
EP2052085A4 (en) Methods for modulating set and uses thereof
GB0609492D0 (en) Therapeutic agents
GB0608928D0 (en) Therapeutic agents
HK1154343A1 (en) Therapeutic combination comprising a cdks inhibitor and an antineoplastic agent
GB0601962D0 (en) Therapeutic agents
ZA200810045B (en) A method and means for varying the content of a display
EP2236150A4 (en) Method for increasing the therapeutic efficacy of curcuminoids and analogues
GB0616214D0 (en) Therapeutic Agents
GB0611152D0 (en) Therapeutic agents
EP2025354A4 (en) Agent for preventing organ adhesion and method for preventing adhesion using the same
PL2121025T3 (en) Methods and compositions for the delivery of a therapeutic agent
EP2077838A4 (en) Methods for the treatment of a related disorders and compositions therefor
GB0620059D0 (en) Therapeutic agents
GB0609676D0 (en) Therapeutic agents
EP2032151A4 (en) Combination therapy method and formulation
EP2097085A4 (en) Therapeutic materials and methods
EP2037954A4 (en) Method for modulating the pharmacokinetics and metabolism of a therapeutic agent
GB0607153D0 (en) Therapeutic Method
EP1790338A4 (en) Therapeutic agent for keratoconjunctiva disorder
EP1757603A4 (en) Therapeutic agent for keratoconjunctiva disorder

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081219

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

R17D Deferred search report published (corrected)

Effective date: 20090423

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/46 20060101ALI20110804BHEP

Ipc: A61K 38/44 20060101ALI20110804BHEP

Ipc: A61K 38/43 20060101AFI20110804BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20110816

17Q First examination report despatched

Effective date: 20130301

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130712